Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV

INTRODUCTION: Sulfonylureas (SU) are commonly used antihyperglycemic agents. VERTIS CV was the cardiovascular outcome study for the sodium-glucose cotransporter 2 inhibitor ertugliflozin. Enrollment of patients in VERTIS CV occurred in two sequential cohorts (Cohort 1 and Cohort 2). METHODS: This su...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Ther
Autori principali: Strojek, Krzysztof, Pandey, A. Shekhar, Dell, Vanessa, Sisson, Melanie, Wang, Shuai, Huyck, Susan, Liu, Jie, Gantz, Ira
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2021
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7994479/
https://ncbi.nlm.nih.gov/pubmed/33694093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01018-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi